Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Michael Schöll

18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease

scientific article published on 25 July 2017

18F-AV-1451 in Parkinson's Disease with and without dementia and in Dementia with Lewy Bodies

scientific article published on 16 March 2018

18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers

scientific article published on 29 June 2016

A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's disease

scientific article published on 06 February 2019

A walk through tau therapeutic strategies

scientific article published on 15 February 2019

Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology

scientific article published on 15 April 2016

Amyloid and tau PET demonstrate region-specific associations in normal older people.

scientific article

Amyloid biomarkers in Alzheimer's disease

scientific article published on April 2015

An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders

scientific article published on 22 April 2020

Association of APOE ɛ4 and Plasma p-tau181 with Preclinical Alzheimer's Disease and Longitudinal Change in Hippocampus Function

scientific article published in 2022

Astrocytosis measured by ¹¹C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer's patients

scientific article published on 31 July 2014

Biomarkers for microglial activation in Alzheimer's disease

scientific article published on November 2011

Biomarkers for tau pathology

scientific article published on 7 December 2018

Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

scientific article published on 01 May 2020

Brain charts for the human lifespan

scientific article published on 6 April 2022

Chronic depressive symptomatology and CSF amyloid beta and tau levels in mild cognitive impairment

scientific article published on 28 June 2018

Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients

scientific article published in January 2013

Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease

scientific article

Comparison of Early-Phase 11C-Deuterium-l-Deprenyl and 11C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease.

scientific article

Correction to: Relevance of biomarkers across different neurodegenerative diseases

scientific article published on 09 June 2020

Detection of Alzheimer's Disease

scientific article published on 21 September 2018

Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative

scientific article published on 26 October 2020

Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders

scientific article published in The Journal of the American Medical Association

Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease

scientific article

Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease

scientific article published on 26 January 2016

Does early cognitive decline require the presence of both tau and amyloid-β?

scientific article published on 01 January 2020

Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity

scientific article published on 31 October 2017

Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography

scientific article

Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease

scientific article published on 11 July 2018

Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.

scientific article published on January 2012

Fluorodeoxyglucose PET in Neurology and Psychiatry.

scientific article published on 12 August 2014

Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation

scientific article published on 30 September 2009

Head-to-head comparison of amplified plasmonic exosome Aβ42 platform and single-molecule array immunoassay in a memory clinic cohort

scientific article published on 28 December 2020

In vivo retention of 18F-AV-1451 in corticobasal syndrome.

scientific article published on 28 July 2017

Increased basal ganglia binding of 18 F-AV-1451 in patients with progressive supranuclear palsy

scientific article published on 6 October 2016

Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration

scholarly article by Nicholas J Ashton et al published 9 January 2019 in Acta neuropathologica communications

Linking Amyloid-β and Tau Deposition in Alzheimer Disease

scientific article published on 30 May 2017

Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers

scientific article published on 13 June 2012

Lower 68 Ga-DOTATOC uptake in nonfunctioning pituitary neuroendocrine tumours compared to normal pituitary gland-A proof-of-concept study

scientific article published on 09 January 2020

Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression

scientific article

Molecular properties underlying regional vulnerability to Alzheimer's disease pathology

scientific article published on 01 September 2018

Multimodality Imaging Approach in Alzheimer disease. Part I: Structural MRI, Functional MRI, Diffusion Tensor Imaging and Magnetization Transfer Imaging.

scientific article published in October 2015

Multimodality Imaging Approaches in Alzheimer's disease. Part II: 1H MR spectroscopy, FDG PET and Amyloid PET.

scientific article published in October 2015

No association of salivary total tau concentration with Alzheimer's disease

scientific article published on 20 June 2018

PET Imaging of Tau Deposition in the Aging Human Brain.

scientific article published on March 2016

Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg

scientific article published on 28 February 2020

Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid-positive individuals

scientific article published on 27 September 2019

Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease

scientific article

Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer's disease

scientific article published on 25 January 2019

Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics

scientific article published on 31 January 2015

Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease

scientific article published on 6 February 2013

Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset

scientific article published on 02 July 2019

Propagation of Tau Pathology: Integrating Insights From Postmortem and In Vivo Studies

scientific article published on 03 October 2019

Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study

scientific article published on 10 May 2018

Regional times to equilibria and their impact on semi-quantification of [18F]AV-1451 uptake

scientific article published on 03 August 2018

Relevance of biomarkers across different neurodegenerative

scientific article published on 13 May 2020

Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease

scientific article published on 19 November 2020

Synaptic vesicle protein 2A as a potential biomarker in synaptopathies

scientific article published on 20 February 2019

Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.

scientific article published on 08 March 2016

Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks

scientific article published on 31 March 2017

Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy

scientific article published on 29 November 2016

Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers

scientific article published in January 2011

University College London/University of Gothenburg PhD course "Biomarkers in neurodegenerative diseases" 2019-course organisation

scientific article published on 04 February 2020

Update on biomarkers for amyloid pathology in Alzheimer's disease

scientific article published on 15 June 2018